Livedoid vasculopathy

Livedoid vasculopathy (LV), also known as livedoid vasculitis or atrophie blanche, is a rare, chronic vascular disorder characterized by recurrent painful ulcerations and purpuric skin lesions, primarily affecting the lower extremities. It is considered a form of thrombotic vasculopathy, leading to occlusion of small dermal blood vessels and tissue necrosis.

Pathophysiology

Livedoid vasculopathy is a non-inflammatory thrombotic vasculopathy involving occlusion of small dermal blood vessels. The underlying mechanisms include:

• Hypercoagulability – Increased clotting tendency leading to microvascular thrombosis.
• Endothelial dysfunction – Damage to small blood vessels in the dermis.
• Impaired fibrinolysis – Reduced breakdown of fibrin deposits contributes to ischemia and tissue necrosis.

Common laboratory findings in LV patients may include:

• Elevated D-dimer – Indicative of hypercoagulability.
• Presence of antiphospholipid antibodies – In some cases, suggesting antiphospholipid syndrome.
• Protein C or S deficiency – Leading to prothrombotic states.

Clinical Features

Livedoid vasculopathy typically presents with:

• Painful purpuric lesions – Often on the ankles and lower legs.
• Ulcerations with white atrophic scars – Known as atrophie blanche.
• Mottled erythema (livedo racemosa) – Reticulated vascular patterns on the skin.
• Recurrent flares – Periodic exacerbations, often worsened in summer months.

The condition is chronic and relapsing, with ulcer healing leaving stellate white scars that are prone to recurrent breakdown.

Diagnosis

Diagnosis is based on:

• Clinical presentation – Characteristic purpuric ulcers and atrophie blanche on the lower legs.
• Doppler ultrasound – To assess microvascular blood flow.
• Skin biopsy findings:
• Fibrin thrombi within dermal blood vessels.
• Absence of leukocytoclastic vasculitis.
• Secondary epidermal necrosis.

Differential Diagnosis

Livedoid vasculopathy should be distinguished from:

• Vasculitis – Inflammatory disorders such as leukocytoclastic vasculitis or polyarteritis nodosa.
• Raynaud’s phenomenon – Reversible vasospasm causing cyanosis and ischemia.
• Chronic venous insufficiency – Can cause stasis ulcers but lacks thrombotic features.
• Antiphospholipid syndrome – A hypercoagulable state with thrombotic events.

Treatment and Management

Since LV is associated with microvascular thrombosis, treatment focuses on anticoagulation and improving circulation.

Pharmacologic Treatment

• Antiplatelet therapy – Aspirin or clopidogrel to reduce platelet aggregation.
• Anticoagulation – Low-molecular-weight heparin or warfarin in patients with hypercoagulability.
• Fibrinolytic therapy – Pentoxifylline or rivaroxaban to enhance microcirculation.
• Pain management – NSAIDs or topical analgesics.
• Wound care – Prevention of secondary infections.

Lifestyle and Supportive Care

• Compression therapy – To improve venous circulation.
• Leg elevation – Reduces venous stasis.
• Avoidance of cold exposure – Prevents vasospasm and worsening ischemia.

Prognosis

Livedoid vasculopathy is a chronic and relapsing condition with periods of remission and exacerbation. Some patients experience spontaneous resolution, while others require long-term anticoagulation to prevent ulcer recurrence.

Related pages

• Vasculopathy
• Atrophie blanche
• Chronic venous insufficiency
• Antiphospholipid syndrome
• Microvascular thrombosis

• Livedoid vasculopathy
  Livedoid vasculopathy